SCHEMBL10169746

SCHEMBL10169746

O=Nc1ccc(-c2ccc(C(=O)NCc3cccc(F)c3)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 9/20 0.53
SRC P12931 2/20 0.53
ROCK1 Q13464 5/20 0.52
NAMPT P43490 1/20 0.52
TP53 P04637 1/20 0.49
MAPT P10636 1/20 0.49
EGFR P00533 1/20 0.49
JAK2 O60674 1/20 0.48
PRKACA P17612 2/20 0.48
GSK3A P49840 2/20 0.48
GSK3B P49841 2/20 0.48
PRKX P51817 2/20 0.48
CLK4 Q9HAZ1 2/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
PRKCQ Q04759 1/20 0.48
RPS6KA5 O75582 1/20 0.48
MAP4K4 O95819 1/20 0.48
PRKCG P05129 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL254175 0.87 SRC (0.69) ROCK2SRCROCK1NAMPTTP53
SCHEMBL254400 0.85 ROCK2 (0.62) ROCK2SRCROCK1NAMPTTP53
SCHEMBL3030331 0.85 HDAC6 (0.63) ROCK2SRCROCK1NAMPTTP53
SCHEMBL3462286 0.81 HDAC2 (0.60) SRCNAMPTTP53MAPT
SCHEMBL20804355 0.80 HPGD (0.57) ROCK2SRCNAMPTTP53MAPT
SCHEMBL25718877 0.80 ROCK2 (0.74) ROCK2ROCK1PRKACAGSK3AGSK3B
SCHEMBL10194841 0.80 MMP13 (0.61) ROCK2NAMPTTP53MAPT
SCHEMBL14082551 0.79 ROCK2 (0.59) ROCK2SRCROCK1MAPTPRKACA
SCHEMBL5338226 0.79 HPGD (0.63) ROCK2NAMPTTP53MAPT
SCHEMBL14082865 0.79 MAPK1 (0.57) ROCK2SRCROCK1NAMPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1836169-B9 COMPOSITIONS AND METHODS OF TREATING CELL PROLIFERATION DISORDERS KINEX PHARMACEUTICALS LLC (US) 2012-07-04 EP disclosed
EP-1836169-B1 COMPOSITIONS AND METHODS OF TREATING CELL PROLIFERATION DISORDERS KINEX PHARMACEUTICALS LLC (US) 2012-02-08 EP disclosed